المؤلفون: Kyaw Z. Thein (11887073), Sarina A. Piha-Paul (8737080), Apostolia Tsimberidou (341493), Daniel D. Karp (10034894), Filip Janku (160679), Siqing Fu (160695), Vivek Subbiah (353745), David S. Hong (8737077), Timothy A. Yap (11887076), Jatin Shah (101993), Denái R. Milton (11887079), Lacey McQuinn (11887082), Jing Gong (105828), Yanyan Tran (11887085), Brett W. Carter (11887088), Rivka Colen (11887091), Funda Meric-Bernstam (478258), Aung Naing (160702)

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Space Science, Biological Sciences not elsewhere classified, Selinexor (KPT 330), Carboplatin, Irinotecan, FOLFIRI, Doxorubicin and cyclophosphamide, Capecitabine and oxaliplatin (XELOX)

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Selinexor_in_combination_with_standard_chemotherapy_in_patients_with_advanced_or_metastatic_solid_tumors/17704589

الاتاحة: https://doi.org/10.6084/m9.figshare.17704589.v1